NEU neuren pharmaceuticals limited

Ann: 2024 Full Year Results webinar, page-71

  1. 34,438 Posts.
    lightbulb Created with Sketch. 9327
    Bank interest income was $11m on average cash of around $210m, around 5.23% interest rate. NEU currently has around $353m cash on hand (As all milestone payments (US$50m x 2 already received; less, monthly cash outflow for R&D and corporate & admin costs ~$3.2m/month).
    Royalties from DAYBUE for 2025 will be around $62m - $67m based on AUD at 65c.
    Interest income on average balance of $300m is very conservative, would earn interest income of around $15m for 2025, imo. That would bring total income for 2025 to ~$80m.

    Regarding the milestone payments, some are easy to meet, like first sales in Europe, US$35m, first sales in Japan, US$15m. That's total of US$50m, probably within next three years.

    Sales milestone payments, are slightly different, it appears 14.3% of the total sales milestone payments are easily achievable, like US$250m in U.S., then next 14.3% are relatively hard to met (i.e. US$500m in U.S.). The total milestone payments for ex-North America are US$363m, 14.3% of that, is US$51.9m. It's very likely that first US$51.9m milestone payments are relatively easy to be earned.
    I read some estimated US peak sales for DAYBUE would be between US$600m and US$800m. If that occurred, another US$50m would come. For next milestone of US$100m for annual sales of US$750m is very hard, imo.

    To sum up, around US$101.9m milestone payments on the sales, are relative easy to be earned in the future; if goes very well, then could earn additional milestone payments up to US$611m, from DAYBUE, and these payments are pure profit as Acadia bears all the costs.

    SKYCLARYS Europe sales are around 43% of the US sales last quarter, not sure if that would be the case for DAYBUE. Let's work on that percentage for now, if US sales are US$400m, then Europe sales would be around US$172m, then total annual royalties would be around US$73m (or $112m, AUD/USD:65c). So I believe our annual royalties from DAYBUE should exceed $100m once successful launching Europe sales.

    All IMO. Not advice.
    Screenshot 2025-03-02 095405.png
    Last edited by 8horse: 02/03/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$13.10
Change
-0.800(5.76%)
Mkt cap ! $1.629B
Open High Low Value Volume
$13.95 $13.96 $12.88 $9.534M 725.6K

Buyers (Bids)

No. Vol. Price($)
1 266 $13.10
 

Sellers (Offers)

Price($) Vol. No.
$13.15 1619 2
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.